Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aerts

Showing results (151-160 of 360) with videos related to

Pageof 36
Sort By:
Annals of Neurology|March 24, 2005
Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's diseaseRussell R Lonser, Stuart Walbridge, Gary J Murray, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2013
No difference in glycosphingolipid metabolism and mitochondrial function in glucocorticoid-induced insulin resistance in healthy menM Brands, D H van Raalte, M João Ferraz, et al.
Chembiochem : a European Journal of Chemical Biology|July 8, 2016
Endo-β-Glucosidase Tag Allows Dual Detection of Fusion Proteins by Fluorescent Mechanism-Based Probes and Activity MeasurementWouter W Kallemeijn, Saskia Scheij, Tineke M Voorn-Brouwer, et al.
Blood Cells, Molecules & Diseases|January 16, 2010
Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort studyJooske M F Boomsma, Laura van Dussen, Maaike G Wiersma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020
A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint InhibitorsMirte Muller, Karlijn Hummelink, Daan P Hurkmans, et al.
Molecular Genetics and Metabolism Reports|July 3, 2020
Therapeutic challenges in two adolescent male patients with Fabry disease and high antibody titresAizeddin A Mhanni, Christiane Auray-Blais, Michel Boutin, et al.
Proteome Science|July 25, 2012
A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian massWouter Wegdam, Perry D Moerland, Danielle Meijer, et al.
Journal of Inherited Metabolic Disease|September 13, 2007
Failure to detect Fabry patients in a cohort of prematurely atherosclerotic malesA C Vedder, V E A Gerdes, B J H M Poorthuis, et al.
Angewandte Chemie (International Ed. in English)|October 29, 2009
Glycosphingolipids--nature, function, and pharmacological modulationTom Wennekes, Richard J B H N van den Berg, Rolf G Boot, et al.
Cancer Immunology Research|May 25, 2017
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC ImmunotherapyFloris Dammeijer, Lysanne A Lievense, Margaretha E Kaijen-Lambers, et al.
Pageof 36

Showing results (151-160 of 360) with videos related to

Sort By:
Pageof 36
Annals of Neurology|March 24, 2005
Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's diseaseRussell R Lonser, Stuart Walbridge, Gary J Murray, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2013
No difference in glycosphingolipid metabolism and mitochondrial function in glucocorticoid-induced insulin resistance in healthy menM Brands, D H van Raalte, M João Ferraz, et al.
Chembiochem : a European Journal of Chemical Biology|July 8, 2016
Endo-β-Glucosidase Tag Allows Dual Detection of Fusion Proteins by Fluorescent Mechanism-Based Probes and Activity MeasurementWouter W Kallemeijn, Saskia Scheij, Tineke M Voorn-Brouwer, et al.
Blood Cells, Molecules & Diseases|January 16, 2010
Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort studyJooske M F Boomsma, Laura van Dussen, Maaike G Wiersma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020
A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint InhibitorsMirte Muller, Karlijn Hummelink, Daan P Hurkmans, et al.
Molecular Genetics and Metabolism Reports|July 3, 2020
Therapeutic challenges in two adolescent male patients with Fabry disease and high antibody titresAizeddin A Mhanni, Christiane Auray-Blais, Michel Boutin, et al.
Proteome Science|July 25, 2012
A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian massWouter Wegdam, Perry D Moerland, Danielle Meijer, et al.
Journal of Inherited Metabolic Disease|September 13, 2007
Failure to detect Fabry patients in a cohort of prematurely atherosclerotic malesA C Vedder, V E A Gerdes, B J H M Poorthuis, et al.
Angewandte Chemie (International Ed. in English)|October 29, 2009
Glycosphingolipids--nature, function, and pharmacological modulationTom Wennekes, Richard J B H N van den Berg, Rolf G Boot, et al.
Cancer Immunology Research|May 25, 2017
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC ImmunotherapyFloris Dammeijer, Lysanne A Lievense, Margaretha E Kaijen-Lambers, et al.
Pageof 36